What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Cancer
His scientific interests lie mostly in Hepatocellular carcinoma, Surgery, Internal medicine, Hepatectomy and Gastroenterology.
His study in Hepatocellular carcinoma is interdisciplinary in nature, drawing from both Cirrhosis, Prospective cohort study, Carcinoma, Pathology and Radiology.
Surgery is frequently linked to Liver function in his study.
In his study, which falls under the umbrella issue of Internal medicine, Chemotherapy is strongly linked to Oncology.
His research integrates issues of Cancer, Metastasis, Preoperative care, Vascular disease and Bile duct in his study of Hepatectomy.
The concepts of his Gastroenterology study are interwoven with issues in Hepatitis C virus, Adjuvant, Proportional hazards model, Adjuvant therapy and Hepatitis B virus.
His most cited work include:
- Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy (952 citations)
- Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma : a preliminary report (896 citations)
- Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. (698 citations)
What are the main themes of his work throughout his whole career to date?
Tadatoshi Takayama spends much of his time researching Internal medicine, Surgery, Hepatocellular carcinoma, Gastroenterology and Hepatectomy.
Internal medicine and Oncology are frequently intertwined in his study.
His Surgery study frequently draws parallels with other fields, such as Liver function.
His Hepatocellular carcinoma research includes elements of Survival rate, Carcinoma, Pathology, Cirrhosis and Radiology.
His studies in Gastroenterology integrate themes in fields like Stage and Confidence interval.
Hepatectomy is often connected to Vein in his work.
He most often published in these fields:
- Internal medicine (37.82%)
- Surgery (34.72%)
- Hepatocellular carcinoma (32.17%)
What were the highlights of his more recent work (between 2014-2021)?
- Hepatocellular carcinoma (32.17%)
- Internal medicine (37.82%)
- Surgery (34.72%)
In recent papers he was focusing on the following fields of study:
Tadatoshi Takayama mainly investigates Hepatocellular carcinoma, Internal medicine, Surgery, Gastroenterology and Radiology.
His Hepatocellular carcinoma research incorporates themes from Confidence interval, Hazard ratio, Hepatectomy and Carcinoma.
His work in Internal medicine addresses subjects such as Oncology, which are connected to disciplines such as Sorafenib.
The study of Surgery is intertwined with the study of Liver function in a number of ways.
In his research on the topic of Gastroenterology, Survival rate is strongly related with Retrospective cohort study.
His study focuses on the intersection of Cancer and fields such as Cancer research with connections in the field of Mutation, Methylation and DNA methylation.
Between 2014 and 2021, his most popular works were:
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial (450 citations)
- Evidence‐based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH‐HCC Guidelines) (248 citations)
- Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion (158 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
His primary scientific interests are in Hepatocellular carcinoma, Internal medicine, Surgery, Gastroenterology and Hepatectomy.
His Hepatocellular carcinoma study combines topics from a wide range of disciplines, such as Prospective cohort study, Carcinoma, Radiology and Radiofrequency ablation.
His study in the fields of Hepatology, Sorafenib and Survival rate under the domain of Internal medicine overlaps with other disciplines such as Population.
His studies deal with areas such as Liver function and General surgery as well as Surgery.
His work carried out in the field of Gastroenterology brings together such families of science as Stage, Hepatitis C, Retrospective cohort study and Hepatitis C virus.
His biological study spans a wide range of topics, including Hemostasis, Cirrhosis, Malignancy and Blood loss.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
